Literature DB >> 8903149

Unraveling mysteries associated with cat-scratch disease, bacillary angiomatosis, and related syndromes.

R Regnery1, J Tappero.   

Abstract

The search for the infectious agents responsible for cat-scratch disease, bacillary angiomatosis, and related syndromes has a long and often circuitous history. Recognition of the etiologic agents and a new understanding of the fundamental features of the epidemiology and natural history of modern day Bartonella (formerly Rochalimaea)-associated diseases culminate a multipartite story that combines clinical medicine, traditional microbiology, and novel technological approaches to solve a long-standing enigma.

Entities:  

Mesh:

Year:  1995        PMID: 8903149      PMCID: PMC2626823          DOI: 10.3201/eid0101.950103

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  41 in total

1.  Clinical and pathological features of bacillary peliosis hepatis in association with human immunodeficiency virus infection.

Authors:  L A Perkocha; S M Geaghan; T S Yen; S L Nishimura; S P Chan; R Garcia-Kennedy; G Honda; A C Stoloff; H Z Klein; R L Goldman
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

2.  Continuing search for the etiology of cat scratch disease.

Authors:  R W Emmons; J L Riggs; J Schachter
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

Review 3.  Cat scratch disease, bacillary angiomatosis, and other infections due to Rochalimaea.

Authors:  K A Adal; C J Cockerell; W A Petri
Journal:  N Engl J Med       Date:  1994-05-26       Impact factor: 91.245

Review 4.  Cat scratch disease.

Authors:  A M Margileth
Journal:  Adv Pediatr Infect Dis       Date:  1993

5.  Cat-scratch disease. An overview based on a study of 1,200 patients.

Authors:  H A Carithers
Journal:  Am J Dis Child       Date:  1985-11

6.  An atypical subcutaneous infection associated with acquired immune deficiency syndrome.

Authors:  M H Stoler; T A Bonfiglio; R T Steigbigel; M Pereira
Journal:  Am J Clin Pathol       Date:  1983-11       Impact factor: 2.493

7.  Proposal of Afipia gen. nov., with Afipia felis sp. nov. (formerly the cat scratch disease bacillus), Afipia clevelandensis sp. nov. (formerly the Cleveland Clinic Foundation strain), Afipia broomeae sp. nov., and three unnamed genospecies.

Authors:  D J Brenner; D G Hollis; C W Moss; C K English; G S Hall; J Vincent; J Radosevic; K A Birkness; W F Bibb; F D Quinn
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

8.  Antibiotic susceptibility patterns in Rochalimaea quintana, the agent of trench fever.

Authors:  W F Myers; D M Grossman; C L Wisseman
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

9.  The epidemiology of bacillary angiomatosis and bacillary peliosis.

Authors:  J W Tappero; J Mohle-Boetani; J E Koehler; B Swaminathan; T G Berger; P E LeBoit; L L Smith; J D Wenger; R W Pinner; C A Kemper
Journal:  JAMA       Date:  1993-02-10       Impact factor: 56.272

10.  Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test.

Authors:  K M Zangwill; D H Hamilton; B A Perkins; R L Regnery; B D Plikaytis; J L Hadler; M L Cartter; J D Wenger
Journal:  N Engl J Med       Date:  1993-07-01       Impact factor: 91.245

View more
  14 in total

1.  Papillary vasoproliferative changes in cat scratch disease.

Authors:  A A Chang; A Zeldovich; N H Sachdev; C Ly; P Beaumont
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

2.  Isolation of Bartonella (Rochalimaea) henselae: effects of methods of blood collection and handling.

Authors:  S A Brenner; J A Rooney; P Manzewitsch; R L Regnery
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 3.  Bartonella spp. as emerging human pathogens.

Authors:  B E Anderson; M A Neuman
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Acute clinical disease in cats following infection with a pathogenic strain of Bartonella henselae (LSU16).

Authors:  K L O'Reilly; R W Bauer; R L Freeland; L D Foil; K J Hughes; K R Rohde; A F Roy; R W Stout; P C Triche
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 5.  Bartonella infection in animals: carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection.

Authors:  E B Breitschwerdt; D L Kordick
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

6.  Evaluation of an in-house cat scratch disease IgM ELISA to detect Bartonella henselae in a routine laboratory setting.

Authors:  M Herremans; J Bakker; M J Vermeulen; J F P Schellekens; M P G Koopmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-05       Impact factor: 3.267

7.  Use of the cell division protein FtsZ as a means of differentiating among Bartonella species.

Authors:  T M Kelly; I Padmalayam; B R Baumstark
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

8.  Isolation and characterization of a beta-D-glucuronidase-producing strain of Escherichia coli serotype O157:H7 in the United States.

Authors:  P S Hayes; K Blom; P Feng; J Lewis; N A Strockbine; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

10.  Bartonella henselae invasion of feline erythrocytes in vitro.

Authors:  J R Mehock; C E Greene; F C Gherardini; T W Hahn; D C Krause
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.